A Single-Center Experience With the Prevention of Post-ERCP Pancreatitis by the Use of Rectal Indomethacin in a High-Risk Population

被引：0
|
作者：
Rubinov, Jason [1 ]
Kutner, Matthew [1 ]
Broder, Arkady [1 ]
D'Souza, Lionel [1 ]
Ascunce, Gil [1 ]
Carr-Locke, David [1 ]
机构：
[1] Mt Sinai Beth Israel, New York, NY USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2014年 / 109卷
关键词：
D O I：
10.14309/00000434-201410002-00286
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
286
引用
收藏
页码：S88 / S88
页数：1
相关论文
共 50 条
  • [41] USE OF CORTICOSTEROIDS IN THE PREVENTION OF POST-ERCP PANCREATITIS
    WEINER, GR
    GEENEN, JE
    HOGAN, WJ
    CATALANO, MF
    GASTROINTESTINAL ENDOSCOPY, 1995, 42 (06) : 579 - 583
  • [42] The Role of Pancreatic Duct Stenting in the Prevention of Post-ERCP Pancreatitis in the Setting of Rectal Indomethacin Usage
    Thiruvengadam, Nikhil R.
    Forde, Kimberly
    Kochman, Michael
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S5 - S5
  • [43] Rectal indomethacin for the prevention of post-ERCP pancreatitis: A meta-analysis of randomized controlled trials
    Shi, Na
    Deng, Lihui
    Altaf, Kiran
    Huang, Wei
    Xue, Ping
    Xia, Qing
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2015, 26 (03): : 236 - 240
  • [44] Rectal Indomethacin Does Not Prevent Post-ERCP Pancreatitis in Consecutive Patients
    Levenick, John M.
    Gordon, Stuart R.
    Fadden, Linda L.
    Levy, L. Campbell
    Rockacy, Matthew J.
    Hyder, Sarah M.
    Lacy, Brian E.
    Bensen, Steven P.
    Parr, Douglas D.
    Gardner, Timothy B.
    GASTROENTEROLOGY, 2016, 150 (04) : 911 - 917
  • [45] Combination Rectal Indomethacin and Topical Epinephrine Is Not Superior to Rectal Indomethacin in the Prevention of Post-ERCP Pancreatitis-A Meta-Analysis
    Laoveeravat, Passisd
    Perisetti, Abhilash
    Vutthikraivit, Wasawat
    Wongjarupong, Nicha
    Garcia-Saenz-de-Sicilia, Mauricio
    Inamdar, Sumant
    Garg, Shashank
    Thandassery, Ragesh
    Tharian, Benjamin
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S61 - S61
  • [46] Post-ERCP Pancreatitis Prophylaxis, Effectiveness of Rectal Indomethacin vs Intravenous Ketorolac in the Pediatric Population
    不详
    PANCREAS, 2022, 51 (07) : 860 - 860
  • [47] Nafamostat Mesilate in the Prevention of Post-ERCP Pancreatitis and Risk Factors for Post-ERCP Pancreattis
    Choi, Cheol Woong
    Kang, Dae Hwan
    Kim, Hyung Wook
    Park, Chan Ho
    Bae, Yong Mock
    Lee, Sang-Yong
    Park, Hyoung-Yoel
    Kim, Yong Wuk
    Lee, Jae Seung
    Kim, Jeong Yeol
    Heo, Jeung Ho
    Jeong, Eul Jo
    GASTROINTESTINAL ENDOSCOPY, 2009, 69 (05) : AB269 - AB269
  • [48] Pre-ERCP Rectal Indomethacin Further Reduces Post-ERCP Pancreatitis Compared With Post-ERCP Strategy: A Multi-Center, Randomized Controlled Trial
    Luo, Hui
    Pan, Yanglin
    Zhang, Rongchun
    Leung, Joseph W.
    Guo, Xuegang
    GASTROINTESTINAL ENDOSCOPY, 2016, 83 (05) : AB139 - AB140
  • [49] RECTAL INDOMETHACIN DOES NOT REDUCE THE RISK OF POST-ERCP PANCREATITIS IN PATIENTS WITH EXISTING BILIARY SPHINCTEROTOMIES
    Ji, Hyun
    Bayudan, Alexis
    Fenton, Cynthia
    Arain, Mustafa
    Dai, Sun-Chuan
    Larsen, Michael
    Avila, Patrick
    Kouanda, Abdul
    GASTROINTESTINAL ENDOSCOPY, 2024, 99 (06) : AB726 - AB726
  • [50] Risk factors of post-ERCP pancreatitis in high-risk patients despite prevention with prophylactic pancreatic stents
    Dubravcsik, Zsolt
    Hritz, Istvan
    Szepes, Attila
    Madacsy, Laszlo
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2020, 55 (01) : 95 - 99
12345